241 related articles for article (PubMed ID: 19689861)
1. Prevalence of pneumococcal polysaccharide vaccine administration and incidence of invasive pneumococcal disease in children in Jamaica aged over 4 years with sickle cell disease diagnosed by newborn screening.
Hardie R; King L; Fraser R; Reid M
Ann Trop Paediatr; 2009 Sep; 29(3):197-202. PubMed ID: 19689861
[TBL] [Abstract][Full Text] [Related]
2. Incidence of invasive pneumococcal disease among individuals with sickle cell disease before and after the introduction of the pneumococcal conjugate vaccine.
Halasa NB; Shankar SM; Talbot TR; Arbogast PG; Mitchel EF; Wang WC; Schaffner W; Craig AS; Griffin MR
Clin Infect Dis; 2007 Jun; 44(11):1428-33. PubMed ID: 17479937
[TBL] [Abstract][Full Text] [Related]
3. Invasive pneumococcal disease in children with sickle cell disease in the pneumococcal conjugate vaccine era.
Martin OO; Moquist KL; Hennessy JM; Nelson SC
Pediatr Blood Cancer; 2018 Jan; 65(1):. PubMed ID: 28675587
[TBL] [Abstract][Full Text] [Related]
4. Risk of Invasive Pneumococcal Disease in Children with Sickle Cell Disease in England: A National Observational Cohort Study, 2010-2015.
Oligbu G; Collins S; Sheppard C; Fry N; Dick M; Streetly A; Ladhani S
Arch Dis Child; 2018 Jul; 103(7):643-647. PubMed ID: 29282225
[TBL] [Abstract][Full Text] [Related]
5. Prompt effect of replacing the 7-valent pneumococcal conjugate vaccine with the 13-valent vaccine on the epidemiology of invasive pneumococcal disease in Norway.
Steens A; Bergsaker MA; Aaberge IS; Rønning K; Vestrheim DF
Vaccine; 2013 Dec; 31(52):6232-8. PubMed ID: 24176490
[TBL] [Abstract][Full Text] [Related]
6. Effectiveness of the 7-valent pneumococcal conjugate vaccine in children with sickle cell disease in the first decade of life.
Adamkiewicz TV; Silk BJ; Howgate J; Baughman W; Strayhorn G; Sullivan K; Farley MM
Pediatrics; 2008 Mar; 121(3):562-9. PubMed ID: 18310206
[TBL] [Abstract][Full Text] [Related]
7. Pneumococcal vaccination programs and the burden of invasive pneumococcal disease in Ontario, Canada, 1995-2011.
Rudnick W; Liu Z; Shigayeva A; Low DE; Green K; Plevneshi A; Devlin R; Downey J; Katz K; Kitai I; Krajden S; Ostrowska K; Richardson D; Richardson S; Sarabia A; Silverman M; Simor AE; Tyrrell G; McGeer A;
Vaccine; 2013 Dec; 31(49):5863-71. PubMed ID: 24099873
[TBL] [Abstract][Full Text] [Related]
8. Impact of pneumococcal conjugate vaccines on burden of invasive pneumococcal disease and serotype distribution of Streptococcus pneumoniae isolates: an overview from Kuwait.
Mokaddas E; Albert MJ
Vaccine; 2012 Dec; 30 Suppl 6():G37-40. PubMed ID: 23228356
[TBL] [Abstract][Full Text] [Related]
9. Invasive pneumococcal disease among children with and without sickle cell disease in the United States, 1998 to 2009.
Payne AB; Link-Gelles R; Azonobi I; Hooper WC; Beall BW; Jorgensen JH; Juni B; Moore M;
Pediatr Infect Dis J; 2013 Dec; 32(12):1308-12. PubMed ID: 23811745
[TBL] [Abstract][Full Text] [Related]
10. Changing epidemiology of invasive pneumococcal disease among White Mountain Apache persons in the era of the pneumococcal conjugate vaccine.
Lacapa R; Bliss SJ; Larzelere-Hinton F; Eagle KJ; McGinty DJ; Parkinson AJ; Santosham M; Craig MJ; O'Brien KL
Clin Infect Dis; 2008 Aug; 47(4):476-84. PubMed ID: 18627249
[TBL] [Abstract][Full Text] [Related]
11. The 23-valent pneumococcal polysaccharide vaccine is effective in elderly adults over 75 years old--Taiwan's PPV vaccination program.
Tsai YH; Hsieh MJ; Chang CJ; Wen YW; Hu HC; Chao YN; Huang YC; Yang CT; Huang CC
Vaccine; 2015 Jun; 33(25):2897-902. PubMed ID: 25936662
[TBL] [Abstract][Full Text] [Related]
12. Pneumococcal bacteremia in a vaccinated pediatric sickle cell disease population.
Ellison AM; Ota KV; McGowan KL; Smith-Whitley K
Pediatr Infect Dis J; 2012 May; 31(5):534-6. PubMed ID: 22228232
[TBL] [Abstract][Full Text] [Related]
13. Invasive pneumococcal disease in homozygous sickle cell disease: Jamaican experience 1973-1997.
Knight-Madden J; Serjeant GR
J Pediatr; 2001 Jan; 138(1):65-70. PubMed ID: 11148514
[TBL] [Abstract][Full Text] [Related]
14. Laboratory surveillance of invasive pneumococcal disease in Australia in 2001 to 2002--implications for vaccine serotype coverage.
Watson M; Bayley K; Bell JM; Gilbert GL; Hogg G; Keil AD; Krause V; Murphy D; Roche P; Smith HV; Stewart MG; Stylianopoulos J; Turnidge J
Commun Dis Intell Q Rep; 2003; 27(4):478-87. PubMed ID: 15508501
[TBL] [Abstract][Full Text] [Related]
15. Laboratory surveillance of invasive pneumococcal disease in Australia, 2003 predicting the future impact of the universal childhood conjugate vaccine program.
Watson M; Roche P; Bayley K; Bell JM; Collignon P; Gilbert GL; Hogg G; Keil AD; Krause V; Murphy D; Smith HV; Brown M; Stylianopoulos J; Turnidge J
Commun Dis Intell Q Rep; 2004; 28(4):455-64. PubMed ID: 15745392
[TBL] [Abstract][Full Text] [Related]
16. Four years of universal pneumococcal conjugate infant vaccination in Germany: impact on incidence of invasive pneumococcal disease and serotype distribution in children.
van der Linden M; Weiß S; Falkenhorst G; Siedler A; Imöhl M; von Kries R
Vaccine; 2012 Aug; 30(40):5880-5. PubMed ID: 22771186
[TBL] [Abstract][Full Text] [Related]
17. Changing serotypes causing childhood invasive pneumococcal disease: Massachusetts, 2001-2007.
Hsu KK; Shea KM; Stevenson AE; Pelton SI;
Pediatr Infect Dis J; 2010 Apr; 29(4):289-93. PubMed ID: 19935447
[TBL] [Abstract][Full Text] [Related]
18. Early impact of PCV7/PCV13 sequential introduction to the national pediatric immunization plan, on adult invasive pneumococcal disease: A nationwide surveillance study.
Regev-Yochay G; Paran Y; Bishara J; Oren I; Chowers M; Tziba Y; Istomin V; Weinberger M; Miron D; Temper V; Rahav G; Dagan R;
Vaccine; 2015 Feb; 33(9):1135-42. PubMed ID: 25613717
[TBL] [Abstract][Full Text] [Related]
19. Pneumococcal Conjugate Vaccine and Clinically Suspected Invasive Pneumococcal Disease.
Palmu AA; Kilpi TM; Rinta-Kokko H; Nohynek H; Toropainen M; Nuorti JP; Jokinen J
Pediatrics; 2015 Jul; 136(1):e22-7. PubMed ID: 26077477
[TBL] [Abstract][Full Text] [Related]
20. Nearly complete elimination of the 7-valent pneumococcal conjugate vaccine serotypes in Tennessee.
Halasa NB; Grijalva CG; Arbogast PG; Talbot TR; Craig AS; Griffin MR; Schaffner W
Pediatr Infect Dis J; 2013 Jun; 32(6):604-9. PubMed ID: 23348816
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
